Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to UY27307ApriorityCriticalpatent/UY27307A1/en
Publication of UY27307A1publicationCriticalpatent/UY27307A1/en
La presente invención se relaciona con una combinación de un inhibidor selectivo de pde4 y un agente anticolinérgico para la administración simultánea, secuencial o por separado por la vía inhalatoria en el tratamiento de una enfermedad obstructiva de las vías respiratorias u otras enfermedades inflamatorias, con la condición de que el agente anticolinérgico no sea una sal de tiotropioThe present invention relates to a combination of a selective pde4 inhibitor and an anticholinergic agent for simultaneous, sequential or separate administration by the inhalation route in the treatment of an obstructive airway disease or other inflammatory diseases, with the condition that the anticholinergic agent is not a tiotropium salt
UY27307A2002-05-242002-05-24
A PDE4 INHIBITOR AND AN ANTI-POLYNERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROUTES
UY27307A1
(en)
Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases.